Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy
Mohammad Rafi Khezri, Reza Varzandeh, Morteza Ghasemnejad‐Berenji
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies
Hamidreza Zalpoor, Abdullatif Akbari, Azam Samei, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 79
Lectins and lectibodies: potential promising antiviral agents
Mohsen Nabi‐Afjadi, Morteza Heydari, Hamidreza Zalpoor, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 42
Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways
Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1533-1539
Open Access | Times Cited: 35
Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases
Hamidreza Zalpoor, Abdullatif Akbari, Mohsen Nabi‐Afjadi
Human Cell (2022) Vol. 35, Iss. 3, pp. 952-954
Open Access | Times Cited: 32
Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management
Vivek P. Chavda, Rajashri Bezbaruah, Nasima Ahmed, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 400-400
Open Access
Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?
Mehran Ghasemzadeh, Javad Ahmadi, Ehteramolsadat Hosseini
Thrombosis Research (2022) Vol. 213, pp. 179-194
Open Access | Times Cited: 26
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?
Mohsen Nabi‐Afjadi, Fatemeh Mohebi, Hamidreza Zalpoor, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 1, pp. 21-35
Open Access | Times Cited: 14
COVID-19 and hepatic injury: Diversity and risk assessment
Fares E.M. Ali, Mostafa K Abd El-Aziz, Mahmoud Ali, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 3, pp. 425-449
Open Access | Times Cited: 12
Safety and efficacy of sirolimus in hospitalised patients with COVID-19 pneumonia
Abhishek Singla, Nusrat Harun, Daniel F. Dilling, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 2, pp. 216-222
Closed Access | Times Cited: 4
Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication
Pasqualino de Antonellis, Veronica Ferrucci, Marco Miceli, et al.
EMBO Reports (2024) Vol. 25, Iss. 7, pp. 2974-3007
Open Access | Times Cited: 4
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
The Role of Tissue Factor In Signaling Pathways of Pathological Conditions and Angiogenesis
Zahra Heidari, Yasaman Naeimzadeh, Jafar Fallahi, et al.
Current Molecular Medicine (2023) Vol. 24, Iss. 9, pp. 1135-1151
Closed Access | Times Cited: 9
The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC)
Ali Norouzi, Mahsa Liaghat, Maryam Bakhtiyari, et al.
Oral Oncology (2023) Vol. 144, pp. 106483-106483
Open Access | Times Cited: 8
Investigation of the Host Kinome Response to Coronavirus Infection Reveals PI3K/mTOR Inhibitors as Betacoronavirus Antivirals
Ethan J. Fritch, Angie L. Mordant, Thomas S.K. Gilbert, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 10, pp. 3159-3177
Closed Access | Times Cited: 8
Neurological complications caused by SARS-CoV-2
Zehan Pang, Ao Tang, Yujie He, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 2
Weighted Gene Co-Expression Network Analysis to Identify Potential Biological Processes and Key Genes in COVID-19-Related Stroke
Gengyu Cen, Liuyu Liu, Jun Wang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 11
Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid
Yong Jiang, Qian Yan, Chengxin Liu, et al.
Computers in Biology and Medicine (2022) Vol. 146, pp. 105601-105601
Open Access | Times Cited: 11
Comprehensive overview of COVID-19-related respiratory failure: focus on cellular interactions
Fahimeh Zamani Rarani, Mohammad Mahdi Zamani, Michael R. Hamblin, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 11
Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
Sara Redenšek, David Vogrinc, Katja Goričar, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6
Hesperetin and the PI3K/AKT pathway: Could their interaction play a role in the entry and replication of the SARS‐CoV‐2?
Mohammad Rafi Khezri, Morteza Ghasemnejad‐Berenji, Donya Moloodsouri
Journal of Food Biochemistry (2022) Vol. 46, Iss. 9
Open Access | Times Cited: 10
Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease
Alexandra Ioana Moatăr, Aimée Rodica Chiş, Cătălin Marian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9239-9239
Open Access | Times Cited: 10
Live and let die: signaling AKTivation and UPRegulation dynamics in SARS-CoVs infection and cancer
Mariana Suaya, Gonzalo M. Sánchez, Antonella Vila, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 10
Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene
Jun Zhang, Zhijia Tang, Guo Xi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
RUNX1 targeting AKT3 promotes alveolar hypercoagulation and fibrinolytic inhibition in LPS induced ARDS
Chuan Xiao, Jiaoyangzi Liu, Yumei Cheng, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases
Hemin Ashayeri Ahmadabad, Somayeh Mohammadi Panah, Hojat Ghasemnejad‐Berenji, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top